Liver transplantation for patients with viral hepatitis

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 1, 2003, Pages 28-31

  Liu, Hao ^a   Liu, Yong Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis recurrence; Liver transplantation

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; GANCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LAMIVUDINE; PROSTAGLANDIN E; PURINE NUCLEOTIDE; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

BLOOD ANALYSIS; CLINICAL PROTOCOL; DELTA AGENT HEPATITIS; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; ETHNOLOGY; GRAFT REJECTION; GRAFT SURVIVAL; HAZARD ASSESSMENT; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TRANSPLANTATION; LONG TERM CARE; RECIPIENT; RECURRENT INFECTION; REVIEW; TREATMENT INDICATION; VIRUS HEPATITIS;

ANTIVIRAL AGENTS; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE; RISK FACTORS;

EID: 0037973385     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;25:1842-1847.
2. Klaus HWB, Grace D, Matthias JB, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997;1:203-210.
3. Uemoto S, Marusawa H, Fujimoto Y, et al. Prophylaxis with hepatitis B immunoglobulin for liver transplant recipients with hepatitis B core antibody-positive donors. The Transplantation Society XVII World Congress. 1998.
4. Testa G, Goldstein RM, Barbara K, et al. Long-term outcome of patients transplanted with livers from hepatitis C positive donors. The Transplantation Society XVII World Congress. 1998.
5. Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996;6: 1327-1333.
6. Goldstein L, Millis JM, Calquhoun SD, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994;9:1393-1395.
7. Bizollon T, Palazzo U, Ducerf C, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;2:500-504.
8. Mazzaferro V, Regalia E, Pulvirenti A, et al. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. Transplant Proc 1997;29:519-521.
9. Fischer L, Sterneck M, Feucht HH, et al. Hepatitis G virus infection in liver transplant patients. The Transplantation Society XVII World Congress. 1998.
10. Betty MH, Samuel KS, Carlos O, et al. Liver transplantation in Asian patients with chronic hepatitis B. Hepatology 1997;12:223-225.
11. Nery JR, Weppler D, Rodriguez M, et al. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation 1998;65: 1615-1621.